AI that learns your uncertainty: a new way to diagnose skin cancer?
NCT ID NCT07468357
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a personalized AI model can help experienced dermatologists more accurately diagnose skin lesions like melanoma. Fifty board-certified dermatologists will use either a standard AI or a new model that adapts to their individual uncertainty. The goal is to see if the personalized AI reduces misdiagnoses and improves doctor confidence.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AI decision support model
What this could lead to
If successful, this could lead to better human-AI teamwork in diagnosing skin cancer, reducing misdiagnoses and improving doctor confidence.
What could go wrong
This is a small, early-stage study with only 50 participants. The expected accuracy gains are small because the doctors are already highly skilled. The AI may not generalize to other settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN LESIONS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••